# GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc. is a company headquartered in Carlsbad, CA, United States.

## Company overview

- **Legal name:** GenMark Diagnostics, Inc.
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Carlsbad, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001487371

## About

GenMark Diagnostics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001487371, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2021-02-25, it reported annual revenue of USD 171,554,000; net income of USD -18,644,000; total assets of USD 223,534,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $171.6M (USD 171,554,000)
- **Net income:** -$18.6M (USD -18,644,000)
- **Total assets:** $223.5M (USD 223,534,000)
- **Cash and equivalents:** $40.6M (USD 40,572,000)
- **Operating cash flow:** $6.1M (USD 6,134,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $88.0M (USD 88,021,000)
- **Net income:** -$47.4M (USD -47,350,000)
- **Total assets:** $111.5M (USD 111,473,000)
- **Cash and equivalents:** $44.4M (USD 44,360,000)
- **Operating cash flow:** -$34.9M (USD -34,926,000)

### FY2017 (period ended 2018-12-31)

- **Revenue:** $70.8M (USD 70,759,000)
- **Net income:** -$50.5M (USD -50,500,000)
- **Total assets:** $93.0M (USD 92,981,000)
- **Cash and equivalents:** $36.3M (USD 36,286,000)
- **Operating cash flow:** -$32.5M (USD -32,512,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $52.5M (USD 52,519,000)
- **Net income:** -$61.9M (USD -61,850,000)
- **Total assets:** $121.6M (USD 121,562,000)
- **Cash and equivalents:** $26.8M (USD 26,754,000)
- **Operating cash flow:** -$53.4M (USD -53,422,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2021-04-22 — period 2021-04-22 — FORM 8-K
- Form SC 13D — filed 2021-03-26 — SC 13D
- Form 8-K — filed 2021-03-15 — period 2021-03-12 — 8-K
- Form 8-K — filed 2021-03-15 — period 2021-03-15 — 8-K
- Form 10-K — filed 2021-02-25 — period 2020-12-31 — 10-K
- Form 8-K — filed 2021-02-25 — period 2021-02-25 — 8-K
- Form 8-K — filed 2021-02-24 — period 2021-02-18 — 8-K
- Form SC 13G — filed 2021-02-17 — CONSONANCE CAPITAL MANAGEMENT LP
- Form SC 13G — filed 2021-02-16 — SCHEDULE 13G
- Form SC 13G — filed 2021-02-16 — CONSONANCE CAPITAL MANAGEMENT LP
- Form SC 13G — filed 2021-02-09
- Form 8-K — filed 2021-01-11 — period 2021-01-11 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/genmark-diagnostics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology